Wang, Haiyun
Yee, Douglas
Potter, David
Jewett, Patricia
Yau, Christina
Beckwith, Heather
Watson, Allison
O’Grady, Nicholas
Wilson, Amy
Brain, Susie
Pohlmann, Paula
Blaes, Anne http://orcid.org/0000-0002-5433-4810
,
Funding for this research was provided by:
National Cancer Institute (5P01CA210961-05)
Article History
Received: 11 May 2023
Accepted: 5 December 2023
First Online: 12 January 2024
Declarations
:
: DP, CY, and DY receive research funding from Quantum Leap Collaborative. The remaining authors have no disclosures.
: All participants provided written informed consent before undergoing screening and a second consent was obtained before treatment was initiated if the individual was eligible after random assignment to open-label treatment arms. All participating sites of this trial received approval from an institutional review board.